View profile for Moe Alsumidaie

Clinical Trial Industry Advisor

You can’t walk into a clinical research conference today without seeing AI everywhere—every booth, every pitch deck, every panel. But here’s the uncomfortable truth: too many of these tools are still black boxes. As Paul McCracken of RadiaNova Consulting put it, “You can’t just have answers arrive and assume that’s the truth.” The best sponsors are demanding gray boxes, not black ones—AI systems that can be interrogated, audited, and explained. Because in a regulated environment, transparency isn’t optional. Before you get wowed by a vendor’s “area under the curve,” ask: → How will this model perform on our data? → Can we see how decisions were reached? → What safeguards exist to detect bias or drift? AI in clinical trials will only earn trust when it’s explainable, not just impressive. What’s the right balance between innovation speed and algorithmic transparency in our field? Full interview: https://lnkd.in/dcZ7KwYr #ClinicalTrials #AI #MachineLearning #Transparency #DataIntegrity Paul J. McCracken, Ph.D. Yunu Lindsay Fleming Jeffrey Sorenson RadiaNova Consulting, LLC

Lauren Selikoff

Fractional CMO, CCO & Communications Advisor | Helping Leaders Build Credibility, Drive Growth & Turn Change Into Opportunity

1d

Sage advice! Every AI prompt needs to include citations and a virtual 'devil's advocate' to sit on AI's cyber shoulder...

To view or add a comment, sign in

Explore content categories